Home LiteratureArticle Details
PMID: 24895606 Published · ppublish English Journal Article Review

Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.

BioMed research international ·Vol. 2014 ·2014-00-00 ·Pages 741018

Andreucci M, Solomon R, Tasanarong A

Abstract

Radiocontrast media (RCM) are medical drugs used to improve the visibility of internal organs and structures in X-ray based imaging techniques. They may have side effects ranging from itching to a life-threatening emergency, known as contrast-induced nephropathy (CIN). We define CIN as acute renal failure occurring within 24-72 hrs of exposure to RCM that cannot be attributed to other causes. It usually occurs in patients with preexisting renal impairment and diabetes. The mechanisms underlying CIN include reduction in medullary blood flow leading to hypoxia and direct tubule cell damage and the formation of reactive oxygen species. Identification of patients at high risk for CIN is important. We have reviewed the risk factors and procedures for prevention, providing a long list of references enabling readers a deep evaluation of them both. The first rule to follow in patients at risk of CIN undergoing radiographic procedure is monitoring renal function by measuring serum creatinine and calculating the eGFR before and once daily for 5 days after the procedure. It is advised to discontinue potentially nephrotoxic medications, to choose radiocontrast media at lowest dosage, and to encourage oral or intravenous hydration. In high-risk patients N-acetylcysteine may also be given.

MeSH Terms
Animals Contrast Media/adverse effects Humans Kidney Diseases/chemically induced,prevention & control Radiography/adverse effects Risk Factors Thyroid Gland/physiopathology
Chemicals
Contrast Media
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Andreucci Michele ORCID
Nephrology Unit, Department of "Health Sciences", Campus "Salvatore Venuta", "Magna Graecia" University, Loc. Germaneto, 88100 Catanzaro, Italy.
Solomon Richard ORCID
University of Vermont College of Medicine, Fletcher Allen Health Care, Burlington, VT, USA.
Tasanarong Adis
Nephrology Unit, Department of Medicine, Faculty of Medicine, Thammasat University, Rangsit Campus, Khlong Luang, Pathum Thani 12121, Thailand.
References (233)
233 references, click to expand
  1. Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast media.
    Biomed Res Int. 2014;2014:249810 PMID: 24745009
  2. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.
    Nephron Clin Pract. 2006;104(1):c20-7 PMID: 16685140
  3. Prevention of contrast-induced nephropathy: an overview.
    Radiol Clin North Am. 2009 Sep;47(5):801-11, v PMID: 19744595
  4. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity.
    AJR Am J Roentgenol. 2008 Aug;191(2):376-82 PMID: 18647905
  5. Nephrotoxicity from contrast media: attenuation with theophylline.
    Radiology. 1995 Apr;195(1):17-22 PMID: 7892462
  6. Acute renal failure after intravenous pyelography in plasma cell myeloma.
    J Am Med Assoc. 1958 Aug 30;167(18):2186-9 PMID: 13563222
  7. Contrast-induced acute kidney injury: how much contrast is safe?
    Nephrol Dial Transplant. 2013 Jun;28(6):1376-83 PMID: 23413087
  8. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Am J Cardiol. 2012 Jan 1;109(1):67-74 PMID: 21943940
  9. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Catheter Cardiovasc Interv. 2002 Nov;57(3):279-83 PMID: 12410497
  10. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
    AJR Am J Roentgenol. 2011 May;196(5):1094-101 PMID: 21512075
  11. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.
    Am J Kidney Dis. 1998 Apr;31(4):674-80 PMID: 9531185
  12. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Br J Radiol. 2003 Aug;76(908):513-8 PMID: 12893691
  13. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions.
    J Am Coll Cardiol. 1999 May;33(6):1756-824 PMID: 10334456
  14. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency.
    Am J Cardiol. 1999 Jan 15;83(2):260-3, A5 PMID: 10073832
  15. Acute anuria following intravenous pyelography in a patient with myelomatosis.
    Acta Med Scand. 1954;150(4):297-302 PMID: 13217726
  16. Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings?
    J Nephrol. 2009 May-Jun;22(3):333-51 PMID: 19557710
  17. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?
    Scand J Urol Nephrol. 1996 Feb;30(1):63-8 PMID: 8727868
  18. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    Circ Cardiovasc Interv. 2010 Aug;3(4):351-8 PMID: 20647563
  19. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
    Am J Med. 2001 Dec 15;111(9):692-8 PMID: 11747848
  20. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography.
    J Am Coll Cardiol. 1991 Feb;17(2):384-90 PMID: 1991894
  21. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
    Am Heart J. 2001 Apr;141(4):677-83 PMID: 11275937
  22. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
    Am J Cardiol. 2009 Oct 1;104(7):921-5 PMID: 19766757
  23. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Nephrol Dial Transplant. 2008 Apr;23(4):1241-5 PMID: 18174269
  24. [Statins in CIN: a problem at least partly solved?].
    G Ital Nefrol. 2013 May-Jun;30(3): PMID: 24873015
  25. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Nephrol Dial Transplant. 2013 Feb;28(2):337-44 PMID: 23314316
  26. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
    Acta Radiol. 2009 Sep;50(7):754-9 PMID: 19452295
  27. Iodinated contrast media and their adverse reactions.
    J Nucl Med Technol. 2008 Jun;36(2):69-74; quiz 76-7 PMID: 18483141
  28. Na+/Ca2+ exchange inhibitor, KB-R7943, attenuates contrast-induced acute 
kidney injury.
    J Nephrol. 2013 Sep-Oct;26(5):877-85 PMID: 23475466
  29. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease.
    Genes Dev. 2004 Sep 15;18(18):2183-94 PMID: 15371333
  30. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis.
    Clin J Am Soc Nephrol. 2009 Oct;4(10):1584-92 PMID: 19713291
  31. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes.
    Hemodial Int. 2010 Oct;14(4):387-92 PMID: 20796046
  32. Contrast-induced nephropathy.
    AJR Am J Roentgenol. 2004 Dec;183(6):1673-89 PMID: 15547209
  33. Effect of contrast media on red cell filtrability and morphology.
    Br J Radiol. 1983 Oct;56(670):707-10 PMID: 6616134
  34. Effects of short- and long-term hypercholesterolemia on contrast-induced acute kidney injury.
    Am J Nephrol. 2012;35(1):80-9 PMID: 22189165
  35. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201 PMID: 20949583
  36. Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction.
    Clin Nephrol. 2007 Nov;68(5):279-86 PMID: 18044259
  37. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.
    Am J Med. 1997 Nov;103(5):368-75 PMID: 9375704
  38. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.
    Nephrol Dial Transplant. 2013 Jun;28(6):1463-71 PMID: 23585585
  39. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Am J Cardiol. 2011 Jul 1;108(1):1-7 PMID: 21529740
  40. Contrast-induced acute kidney injury: is there a risk after intravenous contrast?
    Clin J Am Soc Nephrol. 2008 Sep;3(5):1242-3 PMID: 18701610
  41. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney.
    Kidney Int. 2008 Jul;74(1):91-100 PMID: 18385664
  42. Contrast media augmented apoptosis of cultured renal mesangial, tubular, epithelial, endothelial, and hepatic cells.
    Invest Radiol. 2003 Mar;38(3):177-82 PMID: 12595799
  43. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Nephrol Dial Transplant. 2009 Oct;24(10):3103-7 PMID: 19549691
  44. Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial.
    BMC Nephrol. 2012 Sep 03;13:99 PMID: 22938690
  45. Guidelines for contrast media from the European Society of Urogenital Radiology.
    AJR Am J Roentgenol. 2003 Dec;181(6):1463-71 PMID: 14627556
  46. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    AJR Am J Roentgenol. 2009 Mar;192(3):711-8 PMID: 19234268
  47. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2010 Mar;25(3):747-58 PMID: 19703838
  48. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Radiology. 2005 Jun;235(3):843-9 PMID: 15845795
  49. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro.
    Invest Radiol. 2004 Mar;39(3):149-54 PMID: 15076007
  50. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial.
    Int Urol Nephrol. 2009;41(3):629-34 PMID: 19137409
  51. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
    Kidney Int. 1995 Jan;47(1):254-61 PMID: 7731155
  52. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.
    Am J Cardiol. 2002 Apr 15;89(8):999-1002 PMID: 11950448
  53. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Am J Med Sci. 2010 Jan;339(1):25-30 PMID: 19996728
  54. A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy.
    Kidney Int. 2013 Mar;83(3):446-54 PMID: 23283135
  55. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity.
    Eur Heart J. 2004 Feb;25(3):206-11 PMID: 14972420
  56. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
    J Crit Care. 2011 Dec;26(6):593-9 PMID: 21737245
  57. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects.
    Eur J Endocrinol. 1999 Mar;140(3):264-7 PMID: 10216523
  58. Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week?
    Thyroid. 2004 Jul;14(7):521-4 PMID: 15307941
  59. Pathophysiology of renal tissue damage by iodinated contrast media.
    Clin Exp Pharmacol Physiol. 2011 May;38(5):292-9 PMID: 21348890
  60. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization.
    Circ J. 2008 Sep;72(9):1499-505 PMID: 18724030
  61. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
    Kidney Int. 2000 Apr;57(4):1675-80 PMID: 10760103
  62. Prevention of contrast-induced nephropathy with Na/K citrate.
    Eur Heart J. 2013 Aug;34(30):2362-7 PMID: 23349296
  63. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    J Am Coll Cardiol. 2014 Jan 7-14;63(1):62-70 PMID: 24076297
  64. Iodine excess.
    Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):107-15 PMID: 20172475
  65. Effects of gentamicin, lipopolysaccharide, and contrast media on immortalized proximal tubular cells.
    Ren Fail. 2002 Sep;24(5):655-8 PMID: 12380912
  66. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
    Ann Intern Med. 2009 Nov 3;151(9):631-8 PMID: 19884624
  67. Contrast-induced nephrotoxicity: clinical landscape.
    Kidney Int Suppl. 2006 Apr;(100):S3-7 PMID: 16612398
  68. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Radiology. 2010 Jul;256(1):21-8 PMID: 20574082
  69. Multiple myeloma and contrast media.
    Radiology. 1992 May;183(2):519-21 PMID: 1561361
  70. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.
    Ann Intern Med. 1999 Mar 16;130(6):461-70 PMID: 10075613
  71. Conflicting and new risk factors for contrast induced nephropathy.
    J Urol. 2007 Dec;178(6):2277-83 PMID: 17936812
  72. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Eur Heart J. 2004 Feb;25(3):212-8 PMID: 14972421
  73. Nephrotoxic effects in high-risk patients undergoing angiography.
    N Engl J Med. 2003 Feb 6;348(6):491-9 PMID: 12571256
  74. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization.
    Cardiol Rev. 2009 Nov-Dec;17(6):263-9 PMID: 19829174
  75. Impact of short-duration administration of N-acetylcysteine, probucol and ascorbic acid on contrast-induced cytotoxicity.
    J Nephrol. 2012 Jan-Feb;25(1):56-62 PMID: 21534235
  76. Pravastatin versus simvastatin for prevention of contrast-induced nephropathy.
    J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):376-9 PMID: 21386035
  77. Contrast-induced nephrotoxicity in renal allograft recipients.
    Clin Nephrol. 2000 Jul;54(1):11-4 PMID: 10939751
  78. Potential deleterious effect of furosemide in radiocontrast nephropathy.
    Nephron. 1992;62(4):413-5 PMID: 1300436
  79. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
    Can Assoc Radiol J. 1990 Jun;41(3):133-7 PMID: 2354386
  80. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media.
    Clin Nephrol. 2004 Feb;61(2):98-102 PMID: 14989628
  81. Contrast media-induced nephrotoxicity--questions and answers.
    Br J Radiol. 1998 Apr;71(844):357-65 PMID: 9659127
  82. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
    Radiology. 2013 Apr;267(1):94-105 PMID: 23360737
  83. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association.
    Circulation. 2001 Oct 16;104(16):1985-91 PMID: 11602506
  84. Proximal tubule cell response to radiographic contrast media.
    Am J Physiol Renal Physiol. 2001 Jan;280(1):F61-70 PMID: 11133515
  85. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
    J Interv Cardiol. 2009 Dec;22(6):556-63 PMID: 19732281
  86. Natural course of iodine-induced thyrotoxicosis (Jodbasedow) in endemic goiter area: a 5 year follow-up.
    J Endocrinol Invest. 1989 Apr;12(4):239-44 PMID: 2745935
  87. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Am J Cardiol. 2008 Feb 1;101(3):279-85 PMID: 18237585
  88. Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis.
    Wien Klin Wochenschr. 2008;120(23-24):742-8 PMID: 19122985
  89. Iodinated contrast induced renal vasoconstriction is due in part to the downregulation of renal cortical and medullary nitric oxide synthesis.
    J Vasc Surg. 2006 Aug;44(2):383-91 PMID: 16890873
  90. Dexamethasone ameliorates renal ischemia-reperfusion injury.
    J Am Soc Nephrol. 2009 Nov;20(11):2412-25 PMID: 19797168
  91. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?
    Radiology. 2013 Apr;267(1):106-18 PMID: 23360742
  92. Statin treatment before percutaneous cononary intervention.
    J Thorac Dis. 2013 Jun;5(3):335-42 PMID: 23825770
  93. Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography.
    Blood Coagul Fibrinolysis. 2010 Dec;21(8):750-7 PMID: 20962623
  94. Contrast agents and renal cell apoptosis.
    Eur Heart J. 2008 Oct;29(20):2569-76 PMID: 18468994
  95. Iodine-induced thyroid dysfunction.
    Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):414-9 PMID: 22820214
  96. The role of theophylline in contrast-induced nephropathy: a case-control study.
    Nephrol Dial Transplant. 2002 Nov;17(11):1936-41 PMID: 12401850
  97. Survey of radiologists' knowledge regarding the management of severe contrast material-induced allergic reactions.
    Radiology. 2009 Jun;251(3):691-6 PMID: 19474374
  98. Contrast-induced acute kidney injury.
    Circulation. 2010 Dec 7;122(23):2451-5 PMID: 21135373
  99. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.
    J Am Coll Cardiol. 2007 Aug 14;50(7):584-90 PMID: 17692741
  100. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
    Radiology. 1993 Jul;188(1):171-8 PMID: 8511292
  101. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Am J Cardiol. 2007 Sep 1;100(5):781-6 PMID: 17719320
  102. Contrast-induced nephropathy in critical care.
    Crit Care Nurse. 2012 Dec;32(6):15-23; quiz 1p following page 23 PMID: 23203951
  103. Acute renal failure after excretory urography in multiple myeloma.
    Am J Roentgenol Radium Ther Nucl Med. 1971 Nov;113(3):583-8 PMID: 5127722
  104. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
    Clin J Am Soc Nephrol. 2013 Sep;8(9):1618-31 PMID: 23660180
  105. Thyroiditis and iodide mumps following an angioplasty.
    Nephrol Dial Transplant. 2007 Apr;22(4):1250-2 PMID: 17234667
  106. Prophylaxis against contrast-induced nephropathy.
    Lancet. 1999 May 15;353(9165):1638-9 PMID: 10335780
  107. Acute renal dysfunction after major arteriography.
    AJR Am J Roentgenol. 1985 Dec;145(6):1249-53 PMID: 3877430
  108. Removal of contrast media by different extracorporeal treatments.
    Nephrol Dial Transplant. 2001 Jul;16(7):1471-4 PMID: 11427643
  109. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
    JAMA. 2004 May 19;291(19):2328-34 PMID: 15150204
  110. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group.
    Nephrol Dial Transplant. 2000 Jan;15(1):43-9 PMID: 10607766
  111. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Radiology. 2002 Jun;223(3):772-9 PMID: 12034949
  112. Comparison of iodixanol and iohexol in renal impairment.
    Br J Radiol. 1999 Jul;72(859):701-3 PMID: 10624328
  113. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.
    Int Urol Nephrol. 2008;40(3):749-55 PMID: 18438718
  114. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
    N Engl J Med. 2000 Jul 20;343(3):180-4 PMID: 10900277
  115. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.
    Nephrol Dial Transplant. 2012 Dec;27(12):4263-72 PMID: 23045432
  116. Contrast nephropathy.
    J Am Soc Nephrol. 2000 Jan;11(1):177-182 PMID: 10616853
  117. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency.
    J Cardiol. 2009 Oct;54(2):192-8 PMID: 19782255
  118. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.
    J Comput Assist Tomogr. 2009 Nov-Dec;33(6):819-23 PMID: 19940643
  119. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency.
    Am Surg. 1998 May;64(5):432-6 PMID: 9585778
  120. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic.
    Clin J Am Soc Nephrol. 2008 Jan;3(1):10-8 PMID: 18057306
  121. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Circulation. 2007 Jun 26;115(25):3189-96 PMID: 17562951
  122. [Contrast media and nephrotoxicity: a molecular conundrum].
    G Ital Nefrol. 2011 Jul-Aug;28(4):355 PMID: 21809301
  123. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly.
    Am J Med. 1993 Jul;95(1):78-82 PMID: 8328500
  124. Contrast nephropathy.
    Am J Nephrol. 1981;1(2):69-77 PMID: 6758574
  125. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.
    JAMA. 2008 Sep 3;300(9):1038-46 PMID: 18768415
  126. Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells.
    Biochem Pharmacol. 2006 Nov 15;72(10):1334-42 PMID: 16989777
  127. A prospective study of the effect of nonionic contrast media on thyroid function.
    Thyroid. 1996 Apr;6(2):107-10 PMID: 8733880
  128. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus.
    Mayo Clin Proc. 2000 Dec;75(12):1275-83 PMID: 11126837
  129. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc.
    J Am Diet Assoc. 2001 Mar;101(3):294-301 PMID: 11269606
  130. Sodium butyrate decreases the activation of NF-κB reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy.
    Nephrol Dial Transplant. 2012 Aug;27(8):3136-40 PMID: 22273669
  131. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Clin J Am Soc Nephrol. 2008 Jan;3(1):281-7 PMID: 18003766
  132. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
    Am J Med. 1989 Jun;86(6 Pt 1):649-52 PMID: 2729314
  133. Prevention of nephrotoxicity induced by radiocontrast agents.
    N Engl J Med. 1994 Nov 24;331(21):1449-50 PMID: 7969286
  134. The effect of prophylactic nifedipine on renal function in patients administered contrast media.
    Pharmacotherapy. 1995 Jan-Feb;15(1):59-65 PMID: 7739947
  135. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.
    J Am Coll Cardiol. 2003 Jun 18;41(12):2114-8 PMID: 12821233
  136. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    Catheter Cardiovasc Interv. 2006 Mar;67(3):335-43 PMID: 16489569
  137. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.
    Clin J Am Soc Nephrol. 2010 Jan;5(1):4-9 PMID: 19965528
  138. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.
    JACC Cardiovasc Interv. 2012 Jan;5(1):98-104 PMID: 22230155
  139. Nebivolol: a third-generation beta-adrenergic blocker.
    Ann Pharmacother. 2006 Jul-Aug;40(7-8):1353-60 PMID: 16822893
  140. [Acute renal failure following intravenous pyelography in multiple myeloma].
    Schweiz Med Wochenschr. 1960 Jan 23;90:84-7 PMID: 14442590
  141. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Am J Kidney Dis. 2012 Oct;60(4):576-82 PMID: 22658321
  142. Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide.
    Oxid Med Cell Longev. 2012;2012:831748 PMID: 23097681
  143. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents.
    N Engl J Med. 1994 Nov 24;331(21):1416-20 PMID: 7969280
  144. Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal tubular cells.
    J Cell Biochem. 2014 Feb;115(2):281-9 PMID: 24023012
  145. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Lancet. 2003 Aug 23;362(9384):598-603 PMID: 12944058
  146. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application.
    Kidney Int. 1994 May;45(5):1425-31 PMID: 8072255
  147. Contrast-induced nephropathy: is the picture any clearer?
    Clin J Am Soc Nephrol. 2008 Jan;3(1):261-2 PMID: 18077780
  148. Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.
    AJR Am J Roentgenol. 2002 Sep;179(3):591-6 PMID: 12185025
  149. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.
    Nephrol Dial Transplant. 1999 May;14(5):1146-9 PMID: 10344353
  150. Risk of iodinated contrast material--induced nephropathy with intravenous administration.
    Radiology. 2007 Jun;243(3):622-8 PMID: 17446526
  151. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Am J Kidney Dis. 2008 Jun;51(6):966-75 PMID: 18501784
  152. Prediction of creatinine clearance from serum creatinine.
    Nephron. 1976;16(1):31-41 PMID: 1244564
  153. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
    Endocrinology. 1999 Aug;140(8):3404-10 PMID: 10433193
  154. Nebivolol: new therapy update.
    Cardiol Rev. 2006 Sep-Oct;14(5):259-64 PMID: 16924166
  155. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    N Engl J Med. 2000 Jul 20;343(3):210-2 PMID: 10900284
  156. Acute renal failure in patients with multiple myeloma.
    Am J Med. 1984 Feb;76(2):247-56 PMID: 6695948
  157. The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction.
    Anadolu Kardiyol Derg. 2011 Nov;11(7):613-7 PMID: 21959875
  158. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus.
    Kidney Int. 1994 Jan;45(1):259-65 PMID: 8127017
  159. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions.
    Kidney Int. 2005 Feb;67(2):706-13 PMID: 15673320
  160. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.
    Am J Kidney Dis. 2002 Aug;40(2):221-6 PMID: 12148093
  161. Contrast nephrotoxicity.
    J Am Soc Nephrol. 1994 Aug;5(2):125-37 PMID: 7993992
  162. Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells.
    Chem Biol Interact. 2010 May 14;185(3):253-62 PMID: 20302854
  163. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Am Heart J. 2006 May;151(5):1032.e9-12 PMID: 16644332
  164. Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells.
    Toxicol Sci. 2011 Feb;119(2):408-16 PMID: 21036957
  165. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Radiology. 2009 Jan;250(1):68-86 PMID: 19092091
  166. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Am J Kidney Dis. 2009 Oct;54(4):602-9 PMID: 19535188
  167. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism.
    Arch Intern Med. 2012 Jan 23;172(2):153-9 PMID: 22271121
  168. Risks for renal dysfunction with cardiac angiography.
    Ann Intern Med. 1986 Apr;104(4):501-4 PMID: 3954277
  169. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis.
    Radiology. 2013 Apr;267(1):119-28 PMID: 23319662
  170. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Am Heart J. 2007 Sep;154(3):539-44 PMID: 17719303
  171. Incidence and outcomes of contrast-induced AKI following computed tomography.
    Clin J Am Soc Nephrol. 2008 Sep;3(5):1274-81 PMID: 18463172
  172. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial.
    Nephrol Dial Transplant. 1989;4(12):1030-6 PMID: 2517323
  173. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
    JAMA. 2003 Nov 5;290(17):2284-91 PMID: 14600187
  174. ACE inhibitor or angiotensin II receptor blocker use is a risk factor for contrast-induced nephropathy.
    J Nephrol. 2012 Sep-Oct;25(5):776-81 PMID: 22322819
  175. Iodinated contrast media and the kidney.
    Rev Cardiovasc Med. 2008;9 Suppl 1:S14-23 PMID: 18418313
  176. Contrast-induced nephropathy and long-term adverse events: cause and effect?
    Clin J Am Soc Nephrol. 2009 Jul;4(7):1162-9 PMID: 19556381
  177. Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures.
    J Invasive Cardiol. 2001 Nov;13(11):738-40 PMID: 11689716
  178. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial.
    Radiology. 2006 Jul;240(1):56-64 PMID: 16720865
  179. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
    J Diabetes Complications. 2008 May-Jun;22(3):171-7 PMID: 18413220
  180. Systematic review of the impact of N-acetylcysteine on contrast nephropathy.
    Kidney Int. 2004 Apr;65(4):1366-74 PMID: 15086476
  181. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
    Am J Med. 1990 Nov;89(5):615-20 PMID: 2239981
  182. Early detection of acute renal failure by serum cystatin C.
    Kidney Int. 2004 Sep;66(3):1115-22 PMID: 15327406
  183. Effect of iodinated contrast media on thyroid function in adults.
    Eur Radiol. 2004 May;14(5):902-7 PMID: 14997334
  184. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Nephrol Dial Transplant. 2010 Mar;25(3):759-64 PMID: 19903660
  185. Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.
    Pediatr Cardiol. 2006 Mar-Apr;27(2):238-42 PMID: 16391986
  186. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis.
    Can J Cardiol. 2011 Nov-Dec;27(6):851-8 PMID: 21944277
  187. Contrast-induced nephropathy: what are the true clinical consequences?
    Clin J Am Soc Nephrol. 2008 Jan;3(1):263-72 PMID: 18178787
  188. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.
    Nephrol Dial Transplant. 1998 Feb;13(2):358-62 PMID: 9509446
  189. Nephrotoxicity of ionic and non-ionic contrast material in digital vascular imaging and selective renal arteriography.
    Br J Radiol. 1983 Sep;56(669):631-5 PMID: 6349742
  190. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Radiology. 2013 Sep;268(3):719-28 PMID: 23579046
  191. Preventive effect of nebivolol on contrast-induced nephropathy in rats.
    Nephrol Dial Transplant. 2008 Mar;23(3):853-9 PMID: 17933840
  192. Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker.
    Nephron. 1990;55(3):254-7 PMID: 2370924
  193. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art.
    Nephrol Dial Transplant. 2005 Aug;20(8):1542-50 PMID: 16033768
  194. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.
    Radiology. 2009 Jun;251(3):697-704 PMID: 19366904
  195. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis –.
    Circ J. 2012;76(9):2255-65 PMID: 22975638
  196. Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy.
    Clin J Am Soc Nephrol. 2008 Jan;3(1):288-96 PMID: 18057308
  197. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
    Ren Fail. 2008;30(1):67-72 PMID: 18197546
  198. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Am Heart J. 2009 Mar;157(3):576-83 PMID: 19249432
  199. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy.
    Invest Radiol. 2010 Apr;45(4):188-95 PMID: 20195159
  200. Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity.
    Radiology. 1997 Aug;204(2):297-312 PMID: 9240511
  201. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.
    Circulation. 2012 Dec 18;126(25):3008-16 PMID: 23147173
  202. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controlled trials.
    J Nephrol. 2012 May-Jun;25(3):290-301 PMID: 22252847
  203. Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists.
    Nephrol Dial Transplant. 2002 Aug;17(8):1362-4 PMID: 12147778
  204. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.
    Indian Heart J. 1999 Sep-Oct;51(5):521-6 PMID: 10721643
  205. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization.
    J Invasive Cardiol. 2003 Mar;15(3):133-8 PMID: 12612387
  206. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Radiology. 2012 Jun;263(3):706-13 PMID: 22535561
  207. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
    J Nephrol. 2012 Nov-Dec;25(6):1098-107 PMID: 22383347
  208. Nitric oxide and peroxynitrite in health and disease.
    Physiol Rev. 2007 Jan;87(1):315-424 PMID: 17237348
  209. Does nebivolol prevent contrast-induced nephropathy in humans?
    Clin Cardiol. 2012 Apr;35(4):250-4 PMID: 22262230
  210. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Am J Kidney Dis. 2009 Oct;54(4):610-8 PMID: 19619921
  211. Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
    Am J Kidney Dis. 2009 Apr;53(4):617-27 PMID: 19027212
  212. Prevention of contrast-induced nephropathy with volume supplementation.
    Kidney Int Suppl. 2006 Apr;(100):S16-9 PMID: 16612395
  213. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Am J Med. 2005 Aug;118(8):843-9 PMID: 16084176
  214. Rapid preoperative preparation for severe hyperthyroid Graves' disease.
    J Clin Endocrinol Metab. 2004 May;89(5):2142-4 PMID: 15126532
  215. Pathophysiology of contrast medium-induced nephropathy.
    Kidney Int. 2005 Jul;68(1):14-22 PMID: 15954892
  216. Tamm-Horsfall glycoprotein excretion and aggregation during intravenous urography. Relevance to acute renal failure.
    Invest Radiol. 1985 Jan-Feb;20(1):53-7 PMID: 3980180
  217. Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement.
    Radiology. 2010 Jun;255(3):764-71 PMID: 20406882
  218. Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives.
    Nephrol Dial Transplant. 1998 Mar;13(3):803-6 PMID: 9550679
  219. HOpe for contrast-induced acute kidney injury.
    Kidney Int. 2007 Oct;72(8):907-9 PMID: 17914415
  220. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).
    Eur Radiol. 1999;9(8):1602-13 PMID: 10525875
  221. Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology.
    J Nephrol. 2013 May-Jun;26(3):586-93 PMID: 23543480
  222. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.
    J Am Coll Cardiol. 2011 Aug 23;58(9):907-14 PMID: 21851878
  223. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Circulation. 2004 Nov 2;110(18):2837-42 PMID: 15492300
  224. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
    Kidney Int. 2002 Dec;62(6):2202-7 PMID: 12427146
  225. Acute kidney injury with iodinated contrast.
    Crit Care Med. 2008 Apr;36(4 Suppl):S204-11 PMID: 18382195
  226. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
    JACC Cardiovasc Interv. 2009 Jul;2(7):645-54 PMID: 19628188
  227. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
    Int J Cardiol. 2014 Mar 15;172(2):375-80 PMID: 24502883
  228. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review.
    Medicine (Baltimore). 1979 May;58(3):270-9 PMID: 449662
  229. N-acetyl cysteine ameliorates ischemic renal failure.
    Am J Physiol. 1997 Mar;272(3 Pt 2):F292-8 PMID: 9087670
  230. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
    Radiology. 1992 Mar;182(3):649-55 PMID: 1535876
  231. Contrast-induced nephropathy: definition, epidemiology, and patients at risk.
    Kidney Int Suppl. 2006 Apr;(100):S11-5 PMID: 16612394
  232. Predicting angiography-induced acute renal function impairment: clinical risk model.
    AJR Am J Roentgenol. 1983 Nov;141(5):1027-33 PMID: 6605043
  233. Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury.
    Clin Exp Nephrol. 2014 Jun;18(3):424-31 PMID: 23807430
Article Info
Journal
BioMed research international
Abbr.
Biomed Res Int
ISSN
2314-6141
Published
2014-00-00
Epub
2014-00-11
Pages
741018
Language
English
Region
United States
NLM ID
101600173
PMCID
PMC4034507
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]